Johnson & Johnson (NYSE:JNJ) reported quarterly earnings of $2.59 per share which beat the analyst consensus estimate of $2.57 by 0.78 percent. This is a 4.44 percent increase over earnings of $2.48 per share from the same period last year. The company reported quarterly sales of $24.02 billion which beat the analyst consensus estimate of $23.81 billion by 0.88 percent. This is a 3.00 percent increase over sales of $23.32 billion the same period last year.
EXCLUSIVE: Strategies From 4 Cannabis Industry Leaders To Combat Price Compression, Alternative Cannabinoids
On day two of Benzinga's Cannabis Capital Conference in Miami, industry experts gathered to discuss the pressing issue of price compression in the cannabis sector.
